CDKN2A and cancer: NAF versus normal tissue showed only a significant difference in hypermethylation of CDKN2A (p16INK4a); significant difference in cancer compared to benign ductal lavage for p16 and RASSF1. No significant difference between cancer and precancer samples as well as between precancer and benign samples.